CAV1 and breast cancer: The authors highlight a negative correlation between the survival rate of estrogen receptor α (ERα)-positive breast cancer patients and CAV1 expression, suggesting that CAV1 CGI shore methylation could be used as a prognostic marker for this type of cancer.